Printer Friendly

PERSEPTIVE BIOSYSTEMS NAMES HUBERT M. QUINN VICE PRESIDENT, CHEMICAL PRODUCTION

 PERSEPTIVE BIOSYSTEMS NAMES HUBERT M. QUINN VICE PRESIDENT,
 CHEMICAL PRODUCTION
 CAMBRIDGE, Mass., Aug. 26 /PRNewswire/ -- PerSeptive Biosystems, Inc. (NASDAQ: PBIO) has named Hubert M. Quinn as vice president, chemical production. Quinn previously was manager of chemical production for the company, where he has managed the start-up and operation of the company's chemical production facility in Cambridge, Mass.
 Prior to joining PerSeptive in 1989, Quinn Spent 13 years at the Waters Division of Millipore Corporation, including three years as Plant Manager of its chemical manufacturing plant. From 1974-1984, Quinn held a number of research and development positions at Waters. He began his career as a research chemist at Brandeis University in Waltham, Mass.
 "Hubie Quinn has done an outstanding job of transforming research and development processes into manufacturing protocols," noted Noubar Afeyan, Ph. D., president and CEO of PerSeptive Biosystems. "Due to the efforts of Hubie's team, we have built a facility that can meet the process and manufacturing-scale of the biopharmaceutical industry for Perfusion Chromatography(R) media."
 Quinn holds a bachelor of Science degree in Physics and Chemistry from University College (Dublin, Ireland).
 The biopharmaceutical industry uses the company's POROS(R) media in the scale-up and manufacturing-scale purification of biomolecules, including proteins, peptides and oligonucleotides. POROS materials are used to perform the company's patented purification process, called Perfusion Chromatography(R), and are used in reverse-phase, ion-exchange and other chromatography modes.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products are designed to reduce significantly the time and cost required for the development and manufacture of biopharmaceuticals. The company's current and planned products for the purification and analysis of biomolecules are based on three interrelated core technologies: Perfusion Chromatography, ImmunoDetection(tm) and Rational Surface Design(tm).
 Note: Perfusion Chromatography and POROS are registered trademarks and bioCAD(tm) ImmunoDetection and Rational Surface Design are trademarks of the company.
 -0- 8/26/92
 /CONTACT: Robert A. Fein, vice president and CFO of PerSeptive Biosystems, 617-621-1787; Pam Haslam of Feinstein Partners, 617-577-8110, for PerSeptive Biosystems/
 (PBIO) CO: PerSeptive Biosystems, Inc. ST: Massachusetts IN: MTC SU:


TM -- NE001 -- 3313 08/26/92 08:29 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 26, 1992
Words:361
Previous Article:ASM INTERNATIONAL N.V. REPORTS SECOND QUARTER AND SIX MONTHS OPERATING RESULTS
Next Article:FORD EXPORTS INCREASE 33 PERCENT
Topics:


Related Articles
PERSEPTIVE BIOSYSTEMS ANNOUNCES INITIAL PUBLIC OFFERING
PERSEPTIVE BIOSYSTEMS ANNOUNCES THE EXERCISE OF THE UNDERWRITERS' OPTION TO PURCHASE 375,000 SHARES, COMPLETING ITS INITIAL PUBLIC OFFERING
PERSEPTIVE BIOSYSTEMS SUBMITS DRUG MASTER FILE WITH FDA COVERING POROS CHROMATOGRAPHY MEDIA
PERSEPTIVE BIOSYSTEMS NAMES JOHN CURLING VICE PRESIDENT, INTERNATIONAL BUSINESS DEVELOPMENT
PERSEPTIVE BIOSYSTEMS AND ISIS PHARMACEUTICALS ANNOUNCE THE FORMATION OF PERISIS: A STRATEGIC ALLIANCE FOR OLIGONUCLEOTIDE MANUFACT. TECHNOLOGIES
PERSEPTIVE BIOSYSTEMS NAMES ALAIN MASSOT SENIOR VICE PRESIDENT, INTERNATIONAL
PERSEPTIVE BIOSYSTEMS ANNOUNCES FILING OF REGISTRATION STATEMENT RELATING TO PERSEPTIVE TECHNOLOGIES II CORP.
PERSEPTIVE BIOSYSTEMS ADDS FORMER COO OF DIGITAL EQUIPMENT CORPORATION TO BOARD OF DIRECTORS
PERSEPTIVE BIOSYSTEMS CREATES NEW EXECUTIVE POST
PERSEPTIVE BIOSYSTEMS COMMENCES EXCHANGE OFFER FOR UNITS OF PERSEPTIVE TECHNOLOGIES II CORPORATION

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters